What to Know About the New Covid Shots
The updated shots are now available in the U.S. Here’s who should get them and what to expect.
By
The updated shots are now available in the U.S. Here’s who should get them and what to expect.
By Knvul Sheikh
A new formulation is coming, and there are two main reasons to wait for it.
By Dana G. Smith
While mandates and lockdowns are long gone, the virus isn’t and, for some Americans, neither are masks.
By Campbell Robertson
Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus. But the trial enrolled fewer participants than expected as new Covid vaccines were introduced, and no discernible effect was found.
By Roni Caryn Rabin
U.S. Authorizes a New Round of Covid Boosters
Older Americans and those with weakened immune systems, groups still particularly vulnerable to the virus, may receive additional shots of the reformulated vaccine, federal officials said.
By Apoorva Mandavilli
F.D.A. Plans to Allow a Second Updated Covid Booster for Vulnerable Americans
Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year.
By Noah Weiland and Sharon LaFraniere
Should You Get Another Covid Booster?
Britain and Canada have authorized another round of booster shots for older and immunocompromised citizens. So far, U.S. officials haven’t followed suit.
By Apoorva Mandavilli
AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns.
By Apoorva Mandavilli
Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
By Stephanie Nolen and Rebecca Robbins
Advertisement
Pemgarda, available in the coming weeks, is intended for immunocompromised people who are unlikely to mount an adequate response after vaccination.
By Dani Blum
Four years later, the shadow of the pandemic continues to play a profound role in voters’ pessimism and distrust amid a presidential rematch.
By Lisa Lerer, Jennifer Medina and Reid J. Epstein
Scientists studying the virus’s continuing evolution, and the body’s immune responses, hope to head off a resurgence and to better understand long Covid.
By Apoorva Mandavilli
The federal police accused the former president of falsifying his Covid-19 vaccination records.
By Jack Nicas
Experts offer tips for combating false medical claims in your own circles.
By Dani Blum
And where things stand today.
By David Leonhardt
Are superdodgers real? Is Covid seasonal? And what’s behind its strangest symptoms? Here’s what we’ve learned.
By Knvul Sheikh
Media accounts of a German man’s extreme vaccination history spurred researchers to analyze his immune responses.
By Benjamin Mueller
Infection control lapses, severe staffing shortages and lowering vaccination rates have continued to plague many facilities beyond the pandemic.
By Andrew Jacobs
The agency recommended another round of vaccinations for Americans ages 65 and older.
By Apoorva Mandavilli
Advertisement
Advertisement